Public Profile

Pear Therapeutics, Inc.

Pear Therapeutics, Inc., a pioneering leader in the digital therapeutics industry, is headquartered in the United States. Founded in 2013, the company has made significant strides in developing prescription digital therapeutics designed to treat various mental health and substance use disorders. With a focus on evidence-based solutions, Pear Therapeutics offers unique products such as reSET and reSET-O, which integrate seamlessly with traditional therapies to enhance patient outcomes. These innovative offerings set the company apart in a rapidly evolving market, positioning it as a key player in the intersection of technology and healthcare. Recognised for its commitment to advancing therapeutic options, Pear Therapeutics continues to shape the future of treatment through its cutting-edge digital solutions, addressing critical needs in patient care.

DitchCarbon Score

How does Pear Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Pear Therapeutics, Inc.'s score of 23 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

20%

Pear Therapeutics, Inc.'s reported carbon emissions

Pear Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of concrete data, it is essential to note that many companies in the healthcare and technology sectors are increasingly focusing on sustainability and setting ambitious climate goals. However, without specific initiatives or targets from Pear Therapeutics, their current stance on climate commitments remains vague.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pear Therapeutics, Inc.'s primary industry is Computer and related services (72), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Pear Therapeutics, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pear Therapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

CHESS Health

US
Updated about 1 month ago

Pzizz Ltd.

GB
Updated about 1 month ago

CBT4CBT LLC

US
Updated about 1 month ago

Headspace, Inc.

US
Health and social work services (85)
Updated about 1 month ago

Alkermes

IE
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Sanofi

FR
Chemicals nec
Updated about 23 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers